|LETTER TO EDITOR
|Year : 2018 | Volume
| Issue : 1 | Page : 94
Death outcome with successful treatment of tuberculosis patients
Department of Public Health Sciences, The Graduate School, University of Muhammadiyah Prof. Dr. Hamka (UHAMKA), South Jakarta, Indonesia
|Date of Submission||14-Jan-2018|
|Date of Acceptance||12-Feb-2018|
|Date of Web Publication||12-Oct-2018|
Jl. Warung Buncit Raya No. 17, Pancoran, Jakarta Selatan 12790
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Al Asyary. Death outcome with successful treatment of tuberculosis patients. Int J Prev Med 2018;9:94
I read the previous publication on death outcome after successful treatment of smear-positive tuberculosis (TB). Moosazadeh et al. presented a cohort study in Iranian Registry Setting which concluded that the “Positive smear pulmonary TB even after successful treatment has an adverse effect on the patients' survival and leads to a decrease in their survival rate in the long run.” I agree with the cohort methodology and survivals' data analysis of such an evidence. However, I am concerned about stratification to analyze separately the effect of either diabetes, renal disease, cancer, previous TB treatment, or age group. I am wondering how the adjustable effects' result after these variables are stratified with death status in different population settings.
Furthermore, strategy of directly observed treatments therapy is an established approach to mitigate TB burden, particularly in developing countries. The study of Moosazadeh et al. may reflect on this strategy in a way. A side effects' study is essential to confirm for further.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest
| References|| |
Moosazadeh M, Bahrampour A, Nasehi M, Khanjani N. Survival and predictors of death after successful treatment among smear positive tuberculosis: A cohort study. Int J Prev Med 2014;5:1005-12.
Kleinbaum DG, Klein M. Survival Analysis. New York: Springer; 2010.
World Health Organization, STOP TB Initiative (World Health Organization). Treatment of Tuberculosis: Guidelines. Geneva, Switzerland: World Health Organization; 2010.